Long COVID Syndrome
Conditions
Keywords
long COVID, post COVID
Brief summary
Characterization of patients with long COVID syndrome including symptoms, medical history and persistent organ damage.
Detailed description
Some people are very hesitant to recover from a COVID-19 infection and present persistent symptoms. The participants still suffer after the acute phase of the infection from shortness of breath, coughing, chest pain or fatigue. Therefore, a special interdisciplinary consultation was built. The consulatation is not only addressed to people who have been hospitalized due to COVID-19, but also to those with mild symptoms during infection. During the consultation hours, personal health data are collected that serves as the basis for this research project.
Interventions
OTHERNo intervention
no intervention
Sponsors
Christian Clarenbach
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Long COVID syndrome * age \>= 18 years * Informed consent
Exclusion criteria
* none
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Dyspnea | once through study completion, an average of 6 months. | modified medical research council (scale from 0 to 4). The higher the score the worse the symptoms. |
| self-addressed Quality of life | once through study completion, an average of 6 months | Short form health 36 questionnaire with 8 domains, each rated from 0-100. The higher the score the better subjective quality of life. |
| Thoracic pain | once through study completion, an average of 6 months | assessed by medical interview (reported as yes or no) |
| Medical history | once through study completion, an average of 6 months | List of relevant morbidities assessed as present/not present by medical interview (e.g. respiratory, cardial, neurological, psychiatric diseases by interview and medical records) |
| Fibrosis | once through study completion, an average of 6 months | Assessed by chest CT, rated as present/not present |
| Myocardial damage | once through study completion, an average of 6 months | Assessed by myocardial damage, rated as present/not present |
Countries
Switzerland
Outcome results
None listed